doxorubicin hydrochloride has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Chen, X; Han, L; Huang, X; Jiang, C; Jiang, Y; Liu, J; Qu, X; Zheng, D; Zhong, J | 1 |
| Chen, T; Chen, Y; Ding, Y; Ge, W; Li, S; Liu, Z; Wang, M; Zhang, Q; Zhang, X | 1 |
| Chen, GY; Geng, JJ; Gu, YC; Hai, Y; Hou, XM; Li, PJ; Liu, M; Ma, WP; Shao, CL; Wang, CF; Wei, MY | 1 |
3 other study(ies) available for doxorubicin hydrochloride and Cancer of Liver
| Article | Year |
|---|---|
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
Topics: Animals; Carcinoma, Hepatocellular; Diterpenes; Feces; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Streptomyces; Ursidae | 2017 |
Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Nucleus; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Xenograft Model Antitumor Assays | 2022 |